Glucosamine and Chondroitin in Preventing Inflammation in Overweight Patients

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Subject, Overweight

In brief

This trial studies glucosamine and chondroitin in preventing inflammation in overweight patients. Chronic inflammation contributes to cancer formation, and biomarkers of inflammation have been associated with cancer risk. Glucosamine and chondroitin may prevent inflammation and this trial may help identify the bacteria that help process them in the gut.

Key facts

Study ID
NCT03827161
Run by
Fred Hutchinson Cancer Center
People needed
2
Starts
2017-08-01
Expected to finish
2018-12-01
Last updated by the study team
2019-02-01

Who can join

Age: 20 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.